ND MEDICAL TECHNOLOGY LIMITED reduced its holdings in CH FRONTIER TEC (01661) by 1.992 million shares at an approximate price of HKD 1.67 per share.
On July 17, ND MEDICAL TECHNOLOGY LIMITED reduced its stake in China Frontier Technology Group (01661) by 1,992,000 shares, at a price of HKD 1.6737 per share, for a total amount of approximately HKD 3.334 million.
According to the latest data from the Hong Kong Stock Exchange, on July 17, ND MEDICAL TECHNOLOGY LIMITED reduced its holdings in CH FRONTIER TEC (01661) by 1,992,000 shares, at a price of HKD 1.6737 per share, for a total amount of approximately HKD 3.334 million. After the reduction, the latest number of shares held is 17,026,000, with a current ownership ratio of 8.95%.
This transaction involves other related parties: Wu Meizhen.
Related Articles
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
RECOMMEND
